FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000586718> ?p ?o ?g. }

• W2000586718 endingPage "503" @default.
• W2000586718 startingPage "499" @default.
• W2000586718 abstract "The use of pro re nata (PRN; as needed) psychotropic medication in patients with borderline personality disorder (BPD) has not been well characterized. This study had 3 purposes, which are as follows: (1) to describe the prevalence of PRN psychotropic medication use among patients with BPD and comparison subjects with other personality disorders (OPD) over 14 years of prospective follow-up, (2) to examine the rates reported by patients with BPD who ever recovered and never recovered, and (3) to examine the reasons for taking PRN medication reported by these patients. Overall, the prevalence of PRN psychotropic medication use was initially approximately 3 times higher among patients with BPD than comparison subjects with OPD, with a significant one-third decline in the use of PRN medication reported by patients with BPD over time. In analyses restricted to patients with BPD, patients with BPD who never recovered were approximately twice as likely to use PRN medication than patients with BPD who ever recovered over time. In reasons for use, the rates of PRN medication use to decrease agitation for both diagnostic groups declined significantly over time, whereas they remained significantly higher among patients with BPD. Likewise, patients with BPD who never recovered reported higher use of PRN medication to decrease agitation than patients with BPD who ever recovered over time. The results of this study indicate that PRN psychotropic medication is widely used for the treatment of patients with BPD, particularly those who have not achieved a recovery in both the symptomatic and psychosocial realms. They also suggest that patients with BPD use proportionally more PRN medication to decrease agitation than comparison subjects with OPD, with lower proportional use to reduce agitation found among recovered patients with BPD." @default.
• W2000586718 created "2016-06-24" @default.
• W2000586718 creator A5014885281 @default.
• W2000586718 creator A5030536334 @default.
• W2000586718 creator A5055526341 @default.
• W2000586718 creator A5087833942 @default.
• W2000586718 date "2014-08-01" @default.
• W2000586718 modified "2023-10-02" @default.
• W2000586718 title "Pro Re Nata (As Needed) Psychotropic Medication Use in Patients With Borderline Personality Disorder and Subjects With Other Personality Disorders Over 14 Years of Prospective Follow-Up" @default.
• W2000586718 cites W182725121 @default.
• W2000586718 cites W1966460145 @default.
• W2000586718 cites W1991781869 @default.
• W2000586718 cites W2002571950 @default.
• W2000586718 cites W2016329211 @default.
• W2000586718 cites W2016907600 @default.
• W2000586718 cites W2036289465 @default.
• W2000586718 cites W2057386507 @default.
• W2000586718 cites W2086258798 @default.
• W2000586718 cites W2088829040 @default.
• W2000586718 cites W2092083723 @default.
• W2000586718 cites W2094664948 @default.
• W2000586718 cites W2109696135 @default.
• W2000586718 cites W2120275685 @default.
• W2000586718 cites W2123318349 @default.
• W2000586718 cites W2131533291 @default.
• W2000586718 cites W2132114955 @default.
• W2000586718 cites W2139014761 @default.
• W2000586718 cites W2143589214 @default.
• W2000586718 cites W2144281368 @default.
• W2000586718 cites W2159973407 @default.
• W2000586718 cites W2169266841 @default.
• W2000586718 cites W2993584274 @default.
• W2000586718 doi "https://doi.org/10.1097/jcp.0000000000000132" @default.
• W2000586718 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4077949" @default.
• W2000586718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24875066" @default.
• W2000586718 hasPublicationYear "2014" @default.
• W2000586718 type Work @default.
• W2000586718 sameAs 2000586718 @default.
• W2000586718 citedByCount "9" @default.
• W2000586718 countsByYear W20005867182015 @default.
• W2000586718 countsByYear W20005867182016 @default.
• W2000586718 countsByYear W20005867182017 @default.
• W2000586718 countsByYear W20005867182018 @default.
• W2000586718 countsByYear W20005867182019 @default.
• W2000586718 countsByYear W20005867182023 @default.
• W2000586718 crossrefType "journal-article" @default.
• W2000586718 hasAuthorship W2000586718A5014885281 @default.
• W2000586718 hasAuthorship W2000586718A5030536334 @default.
• W2000586718 hasAuthorship W2000586718A5055526341 @default.
• W2000586718 hasAuthorship W2000586718A5087833942 @default.
• W2000586718 hasBestOaLocation W20005867182 @default.
• W2000586718 hasConcept C118552586 @default.
• W2000586718 hasConcept C126322002 @default.
• W2000586718 hasConcept C134362201 @default.
• W2000586718 hasConcept C150966472 @default.
• W2000586718 hasConcept C15744967 @default.
• W2000586718 hasConcept C187212893 @default.
• W2000586718 hasConcept C187288502 @default.
• W2000586718 hasConcept C188816634 @default.
• W2000586718 hasConcept C2776694085 @default.
• W2000586718 hasConcept C2777308609 @default.
• W2000586718 hasConcept C2777802072 @default.
• W2000586718 hasConcept C2780600973 @default.
• W2000586718 hasConcept C2780699112 @default.
• W2000586718 hasConcept C2781100027 @default.
• W2000586718 hasConcept C3017736306 @default.
• W2000586718 hasConcept C71924100 @default.
• W2000586718 hasConcept C77805123 @default.
• W2000586718 hasConceptScore W2000586718C118552586 @default.
• W2000586718 hasConceptScore W2000586718C126322002 @default.
• W2000586718 hasConceptScore W2000586718C134362201 @default.
• W2000586718 hasConceptScore W2000586718C150966472 @default.
• W2000586718 hasConceptScore W2000586718C15744967 @default.
• W2000586718 hasConceptScore W2000586718C187212893 @default.
• W2000586718 hasConceptScore W2000586718C187288502 @default.
• W2000586718 hasConceptScore W2000586718C188816634 @default.
• W2000586718 hasConceptScore W2000586718C2776694085 @default.
• W2000586718 hasConceptScore W2000586718C2777308609 @default.
• W2000586718 hasConceptScore W2000586718C2777802072 @default.
• W2000586718 hasConceptScore W2000586718C2780600973 @default.
• W2000586718 hasConceptScore W2000586718C2780699112 @default.
• W2000586718 hasConceptScore W2000586718C2781100027 @default.
• W2000586718 hasConceptScore W2000586718C3017736306 @default.
• W2000586718 hasConceptScore W2000586718C71924100 @default.
• W2000586718 hasConceptScore W2000586718C77805123 @default.
• W2000586718 hasIssue "4" @default.
• W2000586718 hasLocation W20005867181 @default.
• W2000586718 hasLocation W20005867182 @default.
• W2000586718 hasLocation W20005867183 @default.
• W2000586718 hasLocation W20005867184 @default.
• W2000586718 hasOpenAccess W2000586718 @default.
• W2000586718 hasPrimaryLocation W20005867181 @default.
• W2000586718 hasRelatedWork W1987020868 @default.
• W2000586718 hasRelatedWork W2000586718 @default.
• W2000586718 hasRelatedWork W2001232586 @default.
• W2000586718 hasRelatedWork W2034117946 @default.
• W2000586718 hasRelatedWork W2060549104 @default.
• W2000586718 hasRelatedWork W2085590314 @default.

• next